Another announcement was made by the Hyderabad based Bharat Biotech International Private Limited over the use of COVAXIN. The Bharat Biotech said the India made COVAXIN for the Novel Coronavirus…
The Hyderabad based pharma company, Bharat Biotech International Private limited agreed to pay compensation if shows adverse side effects on people. Vaccine recipients receiving Bharat Biotech manufactured COVAXIN, would have…
Hyderabad based pharma company, Bharat Biotech International Private Limited and the Indian Council Medical Research (ICMR) prepared vaccine, for the Novel Coronavirus or COVID-19 entered the third phase of the…
The Nizam’s Institute of Medical Sciences (NIMS) of Hyderabad started the phase-III human clinical trials for COVAXIN. The trials begin from the 16th of November. A medical team at NIMS…
On the 12th of September, Hyderabad based Bharat Biotech’s Novel Coronavirus or COVID-19 vaccine candidate COVAXIN, showed successful results on animals. According to the sources, the potential vaccine showed efficacy…
